يعرض 1 - 10 نتائج من 4,519 نتيجة بحث عن '"PERNICIOUS anemia"', وقت الاستعلام: 1.57s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية
  5. 5
    دورية أكاديمية
  6. 6
    دورية أكاديمية

    المصدر: American Journal of Gastroenterology (Lippincott Williams & Wilkins). Mar2022, Vol. 117 Issue 3, p486-490. 5p.

  7. 7
  8. 8
    دورية أكاديمية

    المصدر: Meditsinskiy sovet = Medical Council; № 23 (2023); 157-167 ; Медицинский Совет; № 23 (2023); 157-167 ; 2658-5790 ; 2079-701X

    وصف الملف: application/pdf

    العلاقة: https://www.med-sovet.pro/jour/article/view/8014/7106Test; Lenti MV, Rugge M, Lahner E, Miceli E, Toh BH, Genta RM et al. Autoimmune gastritis. Nat Rev Dis Primers. 2020;6(1):56. https://doi.org/10.1038/s41572020-0187-8Test.; Neumann WL, Coss E, Rugge M, Genta RM. Autoimmune atrophic gastritis – pathogenesis, pathology and management. Nat Rev Gastroenterol Hepatol. 2013;10(9):529–541. https://doi.org/10.1038/nrgastro.2013.101Test.; Toh BH, Sentry JW, Alderuccio F. The causative H+/K+ ATPase antigen in the pathogenesis of autoimmune gastritis. Immunol Today. 2000;21(7):348–354. https://doi.org/10.1016/s0167-5699Test(00)01653-4.; Kulnigg-Dabsch S. Autoimmune gastritis. Wien Med Wochenschr. 2016;166(13-14):424–430. https://doi.org/10.1007/s10354-016-0515-5Test.; Hershko C, Ronson A, Souroujon M, Maschler I, Heyd J, Patz J. Variable hematologic presentation of autoimmune gastritis: age-related progression from iron deficiency to cobalamin depletion. Blood. 2006;107(4):1673–1679. https://doi.org/10.1182/blood-2005-09-3534Test.; Carabotti M, Lahner E, Esposito G, Sacchi MC, Severi C, Annibale B. Upper gastrointestinal symptoms in autoimmune gastritis: A cross-sectional study. Medicine (Baltimore). 2017;96(1):e5784. https://doi.org/10.1097/MD.0000000000005784Test.; Faber K. Achylia gastrica mit Anamie. Med Klin. 1909;5:1310–1325.; Dickey W, Kenny BD, McMillan SA, Porter KG, McConnell JB. Gastric as well as duodenal biopsies may be useful in the investigation of iron deficiency anaemia. Scand J Gastroenterol. 1997;32(5):469–472. https://doi.org/10.3109/00365529709025083Test.; Hershko C, Hoffbrand AV, Keret D, Souroujon M, Maschler I, Monselise Y, Lahad A. Role of autoimmune gastritis, Helicobacter pylori and celiac disease in refractory or unexplained iron deficiency anemia. Haematologica. 2005;90(5):585–595. Available at: https://pubmed.ncbi.nlm.nih.gov/15921373Test.; Claeys D, Faller G, Appelmelk BJ, Negrini R, Kirchner T. The gastric H+,K+ATPase is a major autoantigen in chronic Helicobacter pylori gastritis with body mucosa atrophy. Gastroenterology. 1998;115(2):340–347. https://doi.org/10.1016/s0016-5085Test(98)70200-8.; Toh BH, Chan J, Kyaw T, Alderuccio F. Cutting edge issues in autoimmune gastritis. Clin Rev Allergy Immunol. 2012;42(3):269–278. https://doi.org/10.1007/s12016-010-8218-yTest.; Zhang Y, Weck MN, Schöttker B, Rothenbacher D, Brenner H. Gastric parietal cell antibodies, Helicobacter pylori infection, and chronic atrophic gastritis: evidence from a large population-based study in Germany. Cancer Epidemiol Biomarkers Prev. 2013;22(5):821–826. https://doi.org/10.1158/1055-9965.EPI-12-1343Test.; Wang S-M, Roth MJ, Murphy GA, Dawsey SM, Fan JH, Taylor PR et al. Serologic profile of antiparietal cell antibodies, pepsinogens, and H. pylori and risk of upper gastrointestinal cancer: a nested case-control study in China. Cancer Epidemiol Biomark Prev. 2019;28(12):2022–2029. https://doi.org/10.1158/1055-9965.EPI-19-0512Test.; Ko CW, Siddique SM, Patel A, Harris A, Sultan S, Altayar O, Falck-Ytter Y. AGA Clinical Practice Guidelines on the Gastrointestinal Evaluation of Iron Deficiency Anemia. Gastroenterology. 2020;159(3):1085–1094. https://doi.org/10.1053/j.gastro.2020.06.046Test.; Shayeghi M, Latunde-Dada GO, Oakhill JS, Laftah AH, Takeuchi K, Halliday N et al. Identification of an intestinal heme transporter. Cell. 2005;122(5):789–801. https://doi.org/10.1016/j.cell.2005.06.025Test.; Betesh AL, Santa Ana CA, Cole JA, Fordtran JS. Is achlorhydria a cause of iron deficiency anemia? Am J Clin Nutr. 2015;102(1):9–19. https://doi.org/10.3945/ajcn.114.097394Test.; Skikne BS, Lynch SR, Cook JD. Role of gastric acid in food iron absorption. Gastroenterology. 1981;81(6):1068–1071. Available at: https://pubmed.ncbi.nlm.nih.gov/7286584Test.; Aditi A, Graham DY. Vitamin C, gastritis, and gastric disease: a historical review and update. Dig Dis Sci. 2012;57(10):2504–2515. https://doi.org/10.1007/s10620-012-2203-7Test.; Cооk JD, Brown GM, Valberg LS. The effect of aсhilia gastrica on iron absorbtion. J Clin Invest. 1964;43(6):1185–1191. https://doi.org/10.1172/JCI105002Test.; Annibale B, Capurso G, Chistolini A, D’Ambra G, DiGiulio E, Monarca B, DelleFave G. Gastrointestinal causes of refractory iron deficiency anemia in patients without gastrointestinal symptoms. Am J Med. 2001;111(6):439–445. https://doi.org/10.1016/s0002-9343Test(01)00883-x.; Hershko C, Patz J, Ronson A. The anemia of achylia gastrica revisited. Blood Cells Mol Dis. 2007;39(2):178–183. https://doi.org/10.1016/j.bcmd.2007.03.006Test.; Orgler E, Dabsch S, Malfertheiner P, Schulz С. Autoimmune Gastritis: Update and New Perspectives in Therapeutic Management. Curr Treat Options Gastro. 2023;21:64–77. https://doi.org/10.1007/s11938-02300406-4Test.; Parsons BN, Ijaz UZ, D’Amore R, Burkitt M, Eccles R, Lenzi L et al. Comparison of the human gastric microbiota in hypochlorhydric states arising as a result of Helicobacter pylori-induced atrophic gastritis, autoimmune atrophic gastritis and proton pump inhibitor use. PLoS Pathog. 2017;13(11):e1006653. https://doi.org/10.1371/journal.ppat.1006653Test.; Mohamed M, Thio J, Thomas RS, Phillips J. Pernicious anaemia. BMJ. 2020;369:m1319. https://doi.org/10.1136/bmj.m1319Test.; Kalkan Ç, Soykan I. The Relations Among Serum Ghrelin, Motilin and Gastric Emptying and Autonomic Function in Autoimmune Gastritis. Am J Med Sci. 2018;355(5):428–433. https://doi.org/10.1016/j.amjms.2017.12.021Test.; Centanni M, Marignani M, Gargano L, Corleto VD, Casini A, Delle Fave G et al. Atrophic body gastritis in patients with autoimmune thyroid disease: an underdiagnosed association. Arch Intern Med. 1999;159(15):1726–1730. https://doi.org/10.1001/archinte.159.15.1726Test.; Tursi A, Grattagliano I, De Polo M, Pirrotta E, Bacchin P, Picchio M, De Bastiani R. Noninvasive prediction of chronic atrophic gastritis in autoimmune thyroid disease in primary care. Scand J Gastroenterol. 2014;49(11):1394–1396. https://doi.org/10.3109/00365521.2014.958097Test.; Perros P, Singh RK, Ludlam CA, Frier BM. Prevalence of pernicious anaemia in patients with Type 1 diabetes mellitus and autoimmune thyroid disease. Diabet Med. 2000;17(10):749–751. https://doi.org/10.1046/j.1464-5491.2000.00373.xTest.; De Block CE, De Leeuw IH, Van Gaal LF. Autoimmune gastritis in type 1 diabetes: a clinically oriented review. J Clin Endocrinol Metab. 2008;93(2):363–371. https://doi.org/10.1210/jc.2007-2134Test.; Lahner E, Norman GL, Severi C, Encabo S, Shums Z, Vannella L et al. Reassessment of intrinsic factor and parietal cell autoantibodies in atrophic gastritis with respect to cobalamin deficiency. Am J Gastroenterol. 2009;104(8):2071–2079. https://doi.org/10.1038/ajg.2009.231Test.; Koivurova OP, Koskela R, Blomster T, Ala-Rämi A, Lumme H, Kettunen O et al. Serological Biomarker Panel in Diagnosis of Atrophic Gastritis and Helicobacter pylori Infection in Gastroscopy Referral Patients: Clinical Validation of the New-Generation GastroPanel® Test. Anticancer Res. 2021;41(11):5527–5537. https://doi.org/10.21873/anticanres.15366Test.; Antico A, Tampoia M, Villalta D, Tonutti E, Tozzoli R, Bizzaro N. Clinical usefulness of the serological gastric biopsy for the diagnosis of chronic autoimmune gastritis. Clin Dev Immunol. 2012;2012:520970. https://doi.org/10.1155/2012/520970Test.; Tozzoli R, Kodermaz G, Perosa AR, Tampoia M, Zucano A, Antico A, Bizzaro N. Autoantibodies to parietal cells as predictors of atrophic body gastritis: a five-year prospective study in patients with autoimmune thyroid diseases. Autoimmun Rev. 2010;10(2):80–83. https://doi.org/10.1016/j.autrev.2010.08.006Test.; Chiovato L, Latrofa F, Braverman LE, Pacini F, Capezzone M, Masserini L et al. Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens. Ann Intern Med. 2003;139(5):346–351. https://doi.org/10.7326/0003-4819-139-5_part_1-200309020-00010Test.; Bizzaro N, Tozzoli R, Shoenfeld Y. Are we at a stage to predict autoimmune rheumatic diseases? Arthritis Rheum. 2007;56(6):1736–1744. https://doi.org/10.1002/art.22708Test.; Tozzoli R. The diagnostic role of autoantibodies in the prediction of organ-specific autoimmune diseases. Clin Chem Lab Med. 2008;46(5):577–587. https://doi.org/10.1515/cclm.2008.138Test.; Israeli E, Grotto I, Gilburd B, Balicer RD, Goldin E, Wiik A, Shoenfeld Y. Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease. Gut. 2005;54(9):1232–1236. https://doi.org/10.1136/gut.2004.060228Test.; Yang YX, Brill J, Krishnan P, Leontiadis G. American Gastroenterological Association Clinical Practice Guidelines Committee. American Gastroenterological Association Institute Guideline on the Role of Upper Gastrointestinal Biopsy to Evaluate Dyspepsia in the Adult Patient in the Absence of Visible Mucosal Lesions. Gastroenterology. 2015;149(4):1082–1087. https://doi.org/10.1053/j.gastro.2015.07.039Test.; Shah SC, Piazuelo MB, Kuipers EJ, Li D. AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review. Gastroenterology. 2021;161(4):1325–1332.e7. https://doi.org/10.1053/j.gastro.2021.06.078Test.; Ghosh T, Lewis DI, Axon AT, Everett SM. Review article: methods of measuring gastric acid secretion. Aliment Pharmacol Ther. 2011;33(7):768–781. https://doi.org/10.1111/j.1365-2036.2010.04573.xTest.; Iijima K, Ohara S, Sekine H, Koike T, Kubota Y, Kato K et al. A new endoscopic method of gastric acid secretory testing. Am J Gastroenterol. 1998;93(11):2113–2118. https://doi.org/10.1111/j.1572-0241.1998.00603.xTest.; Toh BH. Diagnosis and classification of autoimmune gastritis. Autoimmun Rev. 2014;13(4-5):459–462. https://doi.org/10.1016/j.autrev.2014.01.048Test.; Okano A, Takakuwa H, Matsubayashi Y. Parietal-cell hyperplasia mimicking sporadic fundic gland polyps in the atrophic mucosa of autoimmune gastritis. Gastrointest Endosc. 2007;66(2):394–395. https://doi.org/10.1016/j.gie.2007.01.022Test.; Park JY, Lam-Himlin D, Vemulapalli R. Review of autoimmune metaplastic atrophic gastritis. Gastrointest Endosc. 2013;77(2):284–292. https://doi.org/10.1016/j.gie.2012.09.033Test.; rugge M, Correa P, Di Mario F, El-Omar E, Fiocca R, Geboes K et al. OLGA staging for gastritis: a tutorial. Dig Liver Dis. 2008;40(8):650–658. https://doi.org/10.1016/j.dld.2008.02.030Test.; Stolte M, Baumann K, Bethke B, Ritter M, Lauer E, Eidt H. Active autoimmune gastritis without total atrophy of the glands. Z Gastroenterol. 1992;30(10):729–735. Available at: https://pubmed.ncbi.nlm.nih.gov/1441676Test.; Pittman ME, Voltaggio L, Bhaijee F, Robertson SA, Montgomery EA. Autoimmune Metaplastic Atrophic Gastritis: Recognizing Precursor Lesions for Appropriate Patient Evaluation. Am J Surg Pathol. 2015;39(12):1611–1620. https://doi.org/10.1097/PAS.0000000000000481Test.; Correa P. A human model of gastric carcinogenesis. Cancer Res. 1988;48(13): 3554–3560. Available at: https://pubmed.ncbi.nlm.nih.gov/3288329Test.; Dinis-Ribeiro M, Areia M, de Vries AC, Marcos-Pinto R, Monteiro-Soares M, O’Connor A et al; European Society of Gastrointestinal Endoscopy; European Helicobacter Study Group; European Society of Pathology; Sociedade Portuguesa de Endoscopia Digestiva. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy. 2012;44(1):74–94. https://doi.org/10.1055/s-0031-1291491Test.; Vannella L, Lahner E, Osborn J, Annibale B. Systematic review: gastric cancer incidence in pernicious anaemia. Aliment Pharmacol Ther. 2013;37(4):375–382. https://doi.org/10.1111/apt.12177Test.; Karakaş Y, Laçin Ş, Kurtulan O, Esin E, Sunar V, Sökmensüer C et al. Prognostic value of the 2017 World Health Organization Classification System for gastric neuroendocrine tumors: A single-center experience. Turk J Gastroenterol. 2020;31(2):91–98. https://doi.org/10.5152/tjg.2020.18919Test.; Creutzfeldt W. The achlorhydria-carcinoid sequence: role of gastrin. Digestion. 1988;39(2):61–79. https://doi.org/10.1159/000199609Test.; Bordi C, D’Adda T, Azzoni C, Pilato FP, Caruana P. Hypergastrinemia and gastric enterochromaffin-like cells. Am J Surg Pathol. 1995;19(Suppl. 1):S8-19. Available at: https://pubmed.ncbi.nlm.nih.gov/7762739Test.; Delle Fave G, Kwekkeboom DJ, Van Cutsem E, Rindi G, Kos-Kudla B, Knigge U et al. Barcelona Consensus Conference participants. ENETS Consensus Guidelines for the management of patients with gastroduodenal neoplasms. Neuroendocrinology. 2012;95(2):74–87. https://doi.org/10.1159/000335595Test.; Nikou GC, Angelopoulos TP. Current concepts on gastric carcinoid tumors. Gastroenterol Res Pract. 2012;2012:287825. https://doi.org/10.1155/2012/287825Test.; Hirota WK, Zuckerman MJ, Adler DG, Davila RE, Egan J, Leighton JA et al. Standards of Practice Committee, American Society for Gastrointestinal Endoscopy. ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc. 2006;63(4):570–580. https://doi.org/10.1016/j.gie.2006.02.004Test.; Chen C, Yang Y, Li P, Hu H. Incidence of Gastric Neoplasms Arising from Autoimmune Metaplastic Atrophic Gastritis: A Systematic Review and Case Reports. J Clin Med. 2023;12(3):1062. https://doi.org/10.3390/jcm12031062Test.; Furuta T, Baba S, Yamade M, Uotani T, Kagami T, Suzuki T et al. High incidence of autoimmune gastritis in patients misdiagnosed with two or more failures of H. pylori eradication. Aliment Pharmacol Ther. 2018;48(3):370–377. https://doi.org/10.1111/apt.14849Test.; Tsuboi M, Niikura R, Hayakawa Y, Hirata Y, Ushiku T, Koike K. et al. Distinct Features of Autoimmune Gastritis in Patients with Open-Type Chronic Gastritis in Japan. Biomedicines. 2020;8(10):419. https://doi.org/10.3390/biomedicines8100419Test.; Gatta L, Scarpignato C. Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth. Aliment Pharmacol Ther. 2017;45(5):604–616. https://doi.org/10.1111/apt.13928Test.; Zhong C, Qu C, Wang B, Liang S, Zeng B. Probiotics for Preventing and Treating Small Intestinal Bacterial Overgrowth: A Meta-Analysis and Systematic Review of Current Evidence. J Clin Gastroenterol. 2017;51(4):300–311. https://doi.org/10.1097/MCG.0000000000000814Test.; Auerbach M, Deloughery T. Single-dose intravenous iron for iron deficiency: a new paradigm. Hematology Am Soc Hematol Educ Program. 2016;2016(1):57–66. https://doi.org/10.1182/asheducation-2016.1.57Test.; Cavalcoli F, Zilli A, Conte D, Massironi S. Micronutrient deficiencies in patients with chronic atrophic autoimmune gastritis: A review. World J Gastroenterol. 2017;23(4):563–572. https://doi.org/10.3748/wjg.v23.i4.563Test.; Kim HW, Kim YH, Han K, Nam GE, Kim GS, Han BD et al. Atrophic gastritis: a related factor for osteoporosis in elderly women. PLoS ONE. 2014;9(7):e101852. https://doi.org/10.1371/journal.pone.0101852Test.; Di Mario F, Rodriguez-Castro KI, Franceschi M, Landi S, Grillo S, Franzoni L et al. Improvement of Symptoms in Patients Affected by Chronic Atrophic Gastritis Using L-Cysteine (Acetium®). Dig Dis. 2023;41(2):198–205. https://doi.org/10.1159/000528168Test.; Jeffries GH, Todd JE, Sleisenger MH. The effect of prednisolone on gastric mucosal histology, gastric secretion, and vitamin B 12 absorption in patients with pernicious anemia. J Clin Invest. 1966;45(5):803–812. https://doi.org/10.1172/JCI105395Test.; Wall AJ, Whittingham S, Mackay IR, Ungar B. Prednisolone and gastric atrophy. Clin Exp Immunol. 1968;3(4):359–366. Available at: https://pubmed.ncbi.nlm.nih.gov/4871897Test.; Moore AR, Boyce M, Steele IA, Campbell F, Varro A, Pritchard DM et al. Netazepide, a gastrin receptor antagonist, normalises tumour biomarkers and causes regression of type 1 gastric neuroendocrine tumours in a nonrandomised trial of patients with chronic atrophic gastritis. PLoS ONE. 2013;8(10):e76462. https://doi.org/10.1371/journal.pone.0076462Test.; Boyce M, Moore AR, Sagatun L, Parsons BN, Varro A, Campbell F et al. Netazepide, a gastrin/cholecystokinin-2 receptor antagonist, can eradicate gastric neuroendocrine tumours in patients with autoimmune chronic atrophic gastritis. Br J Clin Pharmacol. 2017;83(3):466–475. https://doi.org/10.1111/bcp.13146Test.; Ogino K, Hobara T, Ishiyama H, Yamasaki K, Kobayashi H, Izumi Y, Oka S. Antiulcer mechanism of action of rebamipide, a novel antiulcer compound, on diethyldithiocarbamate-induced antral gastric ulcers in rats. Eur J Pharmacol. 1992;212(1):9–13. https://doi.org/10.1016/0014-2999Test(92)90065-c.; Naito Y, Yoshikawa T, Tanigawa T, Sakurai K, Yamasaki K, Uchida M, Kondo M. Hydroxyl radical scavenging by rebamipide and related compounds: electron paramagnetic resonance study. Free Radic Biol Med. 1995;18(1):117–123. https://doi.org/10.1016/0891-5849Test(94)00110-6.; Плотникова ЕЮ, Грачева ТЮ. Эрозивно-язвенные поражения желудочно-кишечного тракта и простагландины: проблемный дуэт. Справочник поликлинического врача. 2016;(4):32–37. Режим доступа: https://www.elibrary.ru/xwpqanTest.; Sun WH, Tsuji S, Tsujii M, Gunawan ES, Kawai N, Kimura A et al. Induction of cyclooxygenase-2 in rat gastric mucosa by rebamipide, a mucoprotective agent. J Pharmacol Exp Ther. 2000;295(2):447–452. Available at: https://pubmed.ncbi.nlm.nih.gov/11046075Test.; Han X, Jiang K, Wang B, Zhou L, Chen X, Li S. Effect of Rebamipide on the Premalignant Progression of Chronic Gastritis: A Randomized Controlled Study. Clin Drug Investig. 2015;35(10):665–673. https://doi.org/10.1007/s40261-015-0329-zTest.; Hou D, Yang M, Hu Z, Yang L. Effects of rebamipide for chronic atrophic gastritis: A protocol for systematic review and meta-analysis. Medicine (Baltimore). 2020;99(25):e20620. https://doi.org/10.1097/MD.0000000000020620Test.; Andreev DN, Maev IV, Dicheva DT. Efficiency of the Inclusion of Rebamipide in the Eradication Therapy for Helicobacter pylori Infection: Meta-Analysis of Randomized Controlled Studies. J Clin Med. 2019;8(9):1498. https://doi.org/10.3390/jcm8091498Test.; Kamada T, Sato M, Tokutomi T, Watanabe T, Murao T, Matsumoto H et al. Rebamipide improves chronic inflammation in the lesser curvature of the corpus after Helicobacter pylori eradication: a multicenter study. Biomed Res Int. 2015;2015:865146. https://doi.org/10.1155/2015/865146Test.; Pimentel-Nunes P, Libânio D, Marcos-Pinto R, Areia M, Leja M, Esposito G et al. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019. Endoscopy. 2019;51(4):365–388. https://doi.org/10.1055/a-0859-1883Test.; Haruma K, Ito M. Review article: clinical significance of mucosal-protective agents: acid, inflammation, carcinogenesis and rebamipide. Aliment Pharmacol Ther. 2003;18(Suppl. 1):153–159. https://doi.org/10.1046/j.1365-2036.18.s1.17.xTest.; rugge M, Fassan M, Pizzi M, Zorzetto V, Maddalo G, Realdon S et al. Autoimmune gastritis: histology phenotype and OLGA staging. Aliment Pharmacol Ther. 2012;35(12):1460–1466. https://doi.org/10.1111/j.1365-2036.2012.05101.xTest.; Gupta S, Li D, El Serag HB, Davitkov P, Altayar O, Sultan S et al. AGA Clinical Practice Guidelines on Management of Gastric Intestinal Metaplasia. Gastroenterology. 2020;158(3):693–702. https://doi.org/10.1053/j.gastro.2019.12.003Test.; https://www.med-sovet.pro/jour/article/view/8014Test

  9. 9
    دورية أكاديمية
  10. 10
    دورية أكاديمية